- Report
- March 2025
- 182 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- July 2023
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 184 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- June 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2023
- 140 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- October 2021
- 113 Pages
Global
From €4095EUR$4,500USD£3,511GBP
PROM Testing is a type of medical testing used in Maternal and Neonatal Care to assess the risk of preterm birth. It involves testing a pregnant woman's cervicovaginal fluid for the presence of certain proteins, which can indicate the risk of preterm labor. PROM Testing is used to identify women at risk of preterm birth, so that they can receive appropriate care and treatment. It is also used to monitor the progress of labor and to assess the risk of complications.
PROM Testing is an important part of Maternal and Neonatal Care, as it helps to identify women at risk of preterm birth and to monitor the progress of labor. It is used in both clinical and home settings, and is becoming increasingly popular as a way to reduce the risk of preterm birth.
Some companies in the PROM Testing market include Alere, Biosynex, Hologic, and Roche Diagnostics. Show Less Read more